Picture of Sinco Pharmaceuticals Holdings logo

6833 Sinco Pharmaceuticals Holdings Cashflow Statement

0.000.00%
hk flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Annual cashflow statement for Sinco Pharmaceuticals Holdings, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line16799.399.998.948.3
Depreciation
Amortisation
Non-Cash Items32.48.6724.225.648.3
Unusual Items
Other Non-Cash Items
Changes in Working Capital99.4-44.1213-38285.6
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities30675.1354-233208
Capital Expenditures-23.5-52.7-64.5-53.1-27.8
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items0.795-66.60.9150.2050.009
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-22.7-119-63.6-52.9-27.8
Financing Cash Flow Items-30437-228107-65.3
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-97.135-190155-236
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash1823.09109-130-59.1